Mayo teams with Arizona State on cancer vaccines
Arizona State University's Biodesign Institute is teaming with researchers at the Mayo Clinic to develop new cancer vaccines. Their approach will be to identify components in the cancer that can be protected against, while looking for vaccines that can have broad utility against a variety of cancers. Common themes in protein signatures produced by cancer tumors.
"This idea of identifying signatures unique to cancer suggests the possibility of preventive vaccines," said Laurence Miller, M.D., director of research and deputy director of the Mayo Clinic Cancer Center. "This approach could avoid many of the problems associated with trying to treat an established tumor."
- check out the release
Related Articles:
Teen vaccine market poised for growth. Report
vaccine market to soar. Report
Comments
Post new comment
Paid Research Reports
- RNA therapy: the next big thing after monoclonal antibodies?
- Biotech M&A Strategies: Deal assessments, trends and future prospects
- The Dermatology Market Outlook to 2013: Competitive landscape, pipeline analysis and growth opportunities
- Pipeline Insight: Cancer Overview - Breast, Gynecological, Genitourinary - Diverse drugs approaching the market for many tumor t
- Sales Force Effectiveness


